Safety and Efficacy of Amyloid-Beta Directed Antibody Therapy in Mild Cognitive Impairment and Dementia with Evidence of Lewy Body Dementia and Amyloid-Beta Pathology (U01 - Clinical Trial Required)
This grant opportunity is seeking applications for placebo-controlled clinical trials to evaluate the effectiveness and safety of FDA-approved monoclonal antibody therapies targeting amyloid in patients with mixed dementia, particularly focusing on Lewy Body Dementias (LBD). The trials should include individuals diagnosed with Alzheimer’s pathology biomarkers and a clinical diagnosis of LBD, s…
This RFA is soliciting applications proposing placebo-controlled, clinical trials to determine the efficacy and safety of FDA approved monoclonal antibody therapies directed against amyloid compared to placebo in diverse "mixed dementia" populations with a focus on Lewy Body Dementias (LBD). In …
Funding Source
Awards & funding
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers